Menu

Experience

Christian Plaza

    • PhaseBio Pharmaceuticals – $46 Million IPO 


    • Entasis Therapeutics – $75 Million IPO 


    • Autolus – $173 Million IPO 


    • Sucampo Sells to Mallinckrodt for $1.2 Billion 


    • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 


    • First US IPO of 2014 for GlycoMimetics 


    • MaxCyte – $202 Million IPO 


    • LAVA Therapeutics – $107 Million IPO 


    • Stori Closes One of Latin America’s Largest Series C Rounds